In summary, our results showed that Gyps activated FXR to regulate lipid metabolism, inhibit hepatic lipid deposition, improve insulin resistance, and reduce inflammatory liver damage in an HFD-induced model of NASH in mice. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.